Long‐term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study

AIM: This phase III, multicentre, randomized study (http://clinicaltrials.gov; NCT01958671) evaluated the efficacy and safety of ertugliflozin monotherapy in adults with inadequately controlled type 2 diabetes (glycated haemoglobin [HbA1c], 7.0% to 10.5% [53‐91 mmol/mol]) despite diet and exercise....

Descripción completa

Detalles Bibliográficos
Autores principales: Aronson, Ronnie, Frias, Juan, Goldman, Allison, Darekar, Amanda, Lauring, Brett, Terra, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969239/
https://www.ncbi.nlm.nih.gov/pubmed/29419917
http://dx.doi.org/10.1111/dom.13251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969239/
https://www.ncbi.nlm.nih.gov/pubmed/29419917
http://dx.doi.org/10.1111/dom.13251

Ejemplares similares